 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
11-16-2023
Insider Buy |
Florian Brand
See Remarks |
$1.16
CAGR »
|
$23,120.00
20,000 shares |
9-13-2023
Insider Buy |
Florian Brand
See Remarks |
$1.45
CAGR »
|
$57,968.00
40,000 shares |
3-29-2023
Insider Buy |
Florian Brand
See Remarks |
$1.48
CAGR »
|
$103,558.00
70,000 shares |
3-29-2023
Insider Buy |
Investment Group LTD. Apeiron
>10% Owner |
$1.32
CAGR »
|
$1,600,443.45
1,214,297 shares |
4-21-2022
Insider Buy |
Investment Group LTD. Apeiron
>10% Owner |
$5.02
CAGR »
|
$684,553.43
136,391 shares |
4-29-2022
Insider Buy |
Investment Group LTD. Apeiron
>10% Owner |
$4.46
CAGR »
|
$252,490.15
56,600 shares |
4-27-2022
Insider Buy |
Investment Group LTD. Apeiron
>10% Owner |
$4.67
CAGR »
|
$308,567.05
66,010 shares |
4-25-2022
Insider Buy |
Investment Group LTD. Apeiron
>10% Owner |
$4.82
CAGR »
|
$297,804.68
61,781 shares |
4-19-2022
Insider Buy |
Investment Group LTD. Apeiron
>10% Owner |
$5.12
CAGR »
|
$612,395.41
119,637 shares |
4-14-2022
Insider Buy |
Investment Group LTD. Apeiron
>10% Owner |
$5.19
CAGR »
|
$25,778.73
4,967 shares |
4-12-2022
Insider Buy |
Investment Group LTD. Apeiron
>10% Owner |
$4.88
CAGR »
|
$269,560.07
55,197 shares |
4-11-2022
Insider Buy |
Investment Group LTD. Apeiron
>10% Owner |
$4.82
CAGR »
|
$538,194.10
111,615 shares |
6-22-2021
Insider Buy |
Investment Group LTD. Apeiron
>10% Owner |
$15.00
CAGR »
|
$10,500,000.00
700,000 shares |
6-22-2021
Insider Buy |
Gregory L. Weaver
Chief Financial Officer |
$15.00
CAGR »
|
$69,990.00
4,666 shares |
6-22-2021
Insider Buy |
Amir H. Kalali
Director |
$15.00
CAGR »
|
$69,990.00
4,666 shares |
6-22-2021
Insider Buy |
Andrea Heslin Smiley
Director |
$15.00
CAGR »
|
$69,990.00
4,666 shares |
6-22-2021
Insider Buy |
Srinivas Rao
See Remarks |
$15.00
CAGR »
|
$52,500.00
3,500 shares |
6-22-2021
Insider Buy |
Alexis de Rosnay
Director |
$15.00
CAGR »
|
$69,990.00
4,666 shares |
6-22-2021
Insider Buy |
Florian Brand
See Remarks |
$15.00
CAGR »
|
$34,995.00
2,333 shares |
6-22-2021
Insider Buy |
Christian Angermayer
Director and >10% Owner |
$15.00
CAGR »
|
$10,500,000.00
700,000 shares |
6-22-2021
Insider Buy |
Michael Auerbach
Director |
$15.00
CAGR »
|
$69,990.00
4,666 shares |
Also See: Institutional Holders of ATAI
Also See: SEC filings
Below we present the annualized performance delivered by ATAI Life Sciences stock since 11-16-2023 (the date of the most recent
insider purchase). The performance of the investment from the time ATAI Life Sciences insider buying occurred is the ultimate
test of whether insiders were right about ATAI being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/17/2023 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$1.11 |
|
| End price/share: |
$1.93 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
73.87% |
|
| Annualized Gain: |
168.52% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$17,387.00 |
|
| Years: |
0.44 |
|
ATAI Life Sciences Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent ATAI Life Sciences insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ATAI
|
|
Free ATAI Email Alerts:
